Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein

Author： Wang Jun-Sheng Zhu Hao-Jie Markowitz John Donovan Jennifer DeVane C.

ISSN： 0033-3158

Source： Psychopharmacology, Vol.187, Iss.4, 2006-09, pp. : 415-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The P-Glycoprotein Multidrug Transporter

By Fardel O. Lecureur V. Guillouzo A.

General Pharmacology, Vol. 27, Iss. 8, 1996-12 ,pp. : 1283-1291

Elsevier

Access to resources Recommend Favorite

Probing Multidrug Resistance P-glycoprotein Transporter Activity with SPECT Radiopharmaceuticals

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 17, 2010-12 ,pp. : 1834-1845

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug Resistance Through the Spectacle of P-Glycoprotein

Current Cancer Drug Targets, Vol. 9, Iss. 3, 2009-05 ,pp. : 281-297

Bentham Science Publishers

Access to resources Recommend Favorite

In silico Strategies to Probe Stereoselective Interactions of Multidrug Resistant Transporter P-glycoprotein

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-08 ,pp. : 824-832

Bentham Science Publishers

Access to resources Recommend Favorite

Trabectedin (ET-743, Yondelis™) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype

By Beumer Jan-Hendrik Buckle Tessa Ouwehand Mariet Franke Niels Lopez-Lazaro Luis Schellens Jan Beijnen Jos Tellingen Olaf

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite